Pharmacovigilance Americas

Programme and agenda

Two days for better pharmacovigilance conversations

Join presentations, panels and speak-out sessions led by senior professionals across drug safety, regulatory affairs, risk management and clinical trials.

15 to 16 September 2027 In person in Boston

Agenda

15 to 16 September 2027 at the Hilton Garden Inn Boston Logan Airport

Two days of keynotes, panels and focused networking around the 2027 theme: The Future of Drug Safety, Intelligence, Evidence and Innovation in Pharmacovigilance.

Day one · Wednesday 15 September 2027 · Intelligence and strategic leadership

  1. – 09:00

    Break

    Registration and networking coffee

  2. – 09:15

    Chair's welcome: Setting the patient safety agenda for 2027

    Dr Susan WelshConference Chair

  3. – 09:40

    Opening keynote: The future of pharmacovigilance, from compliance to strategic impact

    Amrit GillVice President, Opella

  4. – 10:05

    Patient-centred evidence: Bringing benefit–risk into better decisions

    Brett HauberSenior Director, Pfizer

  5. – 10:30

    Panel

    Leadership panel: What should PV leaders prioritise next?

    Moderator: Dr Susan WelshConference Chair

    Panel:Amrit Gill, Brett Hauber, Hina Patel, Chris Flood

  6. – 11:00

    Break

    Networking coffee and exhibition

  7. – 11:30

    Platinum sponsor

    Platinum sponsor speaking slot

    Speaker and topic to be confirmed

  8. – 11:55

    AI in pharmacovigilance: Turning promise into responsible practice

    Karthik MuthusamyExecutive Director, Novo Nordisk

  9. – 12:20

    Building a modern PV function: Governance, accountability and scientific excellence

    Alex KluczkaHead of PV, Bristol Myers Squibb

  10. – 12:45

    From safety data to action: Strengthening signal evaluation and escalation

    Sonam DesaiDirector of PV, Bristol Myers Squibb

  11. – 13:45

    Break

    Networking lunch and exhibition

  12. – 14:10

    Safety leadership in innovative biotech: Building capability as the pipeline evolves

    Hina PatelVice President, Revolution Medicines

  13. – 14:35

    Clinical development safety: Making evidence count at critical decision points

    Chris FloodExecutive Director, Revolution Medicines

  14. – 15:05

    Gold sponsor

    Gold sponsor speaking slot

    Speaker and topic to be confirmed

  15. – 15:30

    Panel

    Interactive panel: The AI-enabled safety function. Where do humans add most value?

    Moderator: Dr Susan WelshConference Chair

    Panel:Karthik Muthusamy, Alex Kluczka, Sonam Desai, Chris Flood

  16. – 16:00

    Break

    Networking coffee and exhibition

  17. – 16:25

    Scaling pharmacovigilance in emerging biotech: Building for the next stage

    Lana PodolskiVice President, Celcuity

  18. – 16:50

    Global safety leadership: Aligning science, systems and patient impact

    Stephen KuskeVice President, Sanofi

  19. – 17:00

    Chair's closing reflections and day two preview

    Dr Susan WelshConference Chair

Day two · Thursday 16 September 2027 · Evidence, innovation and practical impact

  1. – 09:00

    Break

    Networking coffee and exhibition

  2. – 09:10

    Chair's opening: From ideas to implementation

    Dr Susan WelshConference Chair

  3. – 09:40

    Opening keynote: Advancing patient safety across a changing therapeutic landscape

    Harsha ShettySenior Director, CSL

  4. – 10:10

    PV in emerging biotech: Building robust systems for complex development programmes

    Priya JainVice President, Tango Therapeutics

  5. – 10:40

    Cell therapy safety: Addressing complexity across the patient journey

    Uma ArunagiriVice President, Kite Pharma

  6. – 11:10

    Break

    Networking coffee and exhibition

  7. – 11:40

    Silver sponsor

    Silver sponsor speaking slot

    Speaker and topic to be confirmed

  8. – 12:10

    Safety in rapid innovation: Integrating evidence across the product lifecycle

    Suzanne TraceyVice President, Moderna

  9. – 12:35

    Panel

    Scientific panel: New modalities, new safety questions. Is traditional PV enough?

    Moderator: Dr Susan WelshConference Chair

    Panel:Harsha Shetty, Priya Jain, Uma Arunagiri, Suzanne Tracey

  10. – 13:00

    Local safety, global standards: Strengthening operational pharmacovigilance

    Jeniffer BarnesAssociate Director, Teva

  11. – 14:00

    Break

    Networking lunch and exhibition

  12. – 14:30

    Premium sponsor

    Premium sponsor speaking slot

    Speaker and topic to be confirmed

  13. – 15:05

    Case forum

    Interactive case forum: A safety signal emerges. What happens next?

    Facilitators:Sonam Desai, Chris Flood, Harsha Shetty

    Signal assessment, benefit–risk, escalation and risk communication

  14. – 15:30

    Discussion

    Evidence to action: Making benefit–risk communication meaningful

    Brett Hauber and Priya Jain

    Moderator: Dr Susan WelshConference Chair

  15. – 16:00

    Break

    Networking coffee and exhibition

  16. – 16:40

    Panel

    Closing leadership panel: The next chapter of global pharmacovigilance

    Moderator: Dr Susan WelshConference Chair

    Panel:Amrit Gill, Karthik Muthusamy, Uma Arunagiri, Suzanne Tracey

  17. – 16:55

    Conference commitments: Five actions to take back to your organisation

    Dr Susan WelshConference Chair

  18. – 17:00

    Closing remarks

    Dr Susan WelshConference Chair

Proposed programme, subject to speaker confirmation. All times are US Eastern Time (EDT).

Programme brochure

Get the full 2027 programme.

The brochure has the two-day agenda, confirmed speakers, session themes and pass options. Our team will email it to you shortly.

  • Full two-day agenda and session themes
  • Speakers from Pfizer, Sanofi, BMS, Moderna, CSL and more
  • what your pass includes

Get a brochure

Choose the delegate or sponsorship brochure. Please use your work email; we send it to this address.